1. Hepatic myeloid-derived suppressor cells in cancer

   • José Medina-Echeverz
   • Tobias Eggert
   • Tim F. Greten

   Review 02 July 2015 Pages: 931 - 940

   

2. Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity

   • Masato Muto
   • Muhammad Baghdadi
   • Ken-ichiro Seino

   Original Article 24 April 2015 Pages: 941 - 949

   

3. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

   • Subhashis Sarkar
   • Michel van Gelder
   • Lotte Wieten

   Original Article Open access 29 April 2015 Pages: 951 - 963

   

4. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion

   • Fei Wang
   • Li Yang
   • Yi Zhang

   Original Article 06 May 2015 Pages: 965 - 976

   

5. Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer

   • Joseph P. Balint
   • Elizabeth S. Gabitzsch
   • Frank R. Jones

   Original Article 09 May 2015 Pages: 977 - 987

   

6. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation

   • Marilène Binsfeld
   • Muriel Hannon
   • Jo Caers

   Original Article 14 May 2015 Pages: 989 - 998

   

7. Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

   • Riccardo Danielli
   • Roberto Patuzzo
   • Mario Santinami

   Original Article 14 May 2015 Pages: 999 - 1009

   

8. Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis

   • Snezana Zivancevic-Simonovic
   • Olgica Mihaljevic
   • Miodrag Colic

   Original Article 14 May 2015 Pages: 1011 - 1019

   

9. Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study

   • Katy J. McCann
   • Rosemary Godeseth
   • Christian H. Ottensmeier

   Original Article Open access 16 May 2015 Pages: 1021 - 1032

   

10. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice

    • Laura Jeanbart
    • Iraklis C. Kourtis
    • Jeffrey A. Hubbell

    Original Article Open access 16 May 2015 Pages: 1033 - 1046

    

11. Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial

    • Yoshinari Maeda
    • Kiyoshi Yoshimura
    • Masaaki Oka

    Original Article 16 May 2015 Pages: 1047 - 1056

    

12. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice

    • Zili Wang
    • Esteban Celis

    Original Article 19 May 2015 Pages: 1057 - 1066

    

13. Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain

    • Alberto Anel
    • Luis Martínez-Lostao
    • Julián Pardo

    Meeting Report 16 June 2015 Pages: 1067 - 1069